94-7167. Manufacturer of Controlled Substances; Application

[Federal Register Volume 59, Number 59 (Monday, March 28, 1994)]
[Unknown Section]
[Page ]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-7167]


[Federal Register: March 28, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 25, 1994, 
Mallinckrodt Specialty Chemicals Company, Mallinckrodt & Second 
Streets, St. Louis, Missouri 63147, made application to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below: 

------------------------------------------------------------------------
                           Drug                               Schedule  
------------------------------------------------------------------------
Cocaine (9041)............................................  II          
Codeine (9050)............................................  II          
Diprenorphine (9058)......................................  II          
Etorphine Hydrochloride (9059)............................  II          
Dihydrocodeine (9120).....................................  II          
Oxycodone (9143)..........................................  II          
Hydromorphone (9150)......................................  II          
Diphenoxylate (9170)......................................  II          
Hydrocodone (9193)........................................  II          
Levorphanol (9220)........................................  II          
Meperidine (9230).........................................  II          
Methadone (9250)..........................................  II          
Methadone-intermediate (9254).............................  II          
Dextropropoxyphene, bulk (non-dosage forms) (9273)........  II          
Morphine (9300)...........................................  II          
Thebaine (9333)...........................................  II          
Opium extracts (9610).....................................  II          
Opium fluid extract (9620)................................  II          
Opium tincture (9630).....................................  II          
Opium powdered (9639).....................................  II          
Opium granulated (9640)...................................  II          
Oxymorphone (9652)........................................  II          
Alfentanil (9737).........................................  II          
Sufentanil (9740).........................................  II          
Fentanyl (9801)...........................................  II          
------------------------------------------------------------------------

    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, DC 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than April 27, 1994.

    Dated: March 18, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 94-7167 Filed 3-25-94; 8:45 am]
BILLING CODE 4410-09-M